Method for treating esophageal variceal bleeding through sclerosis therapy
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 赵立地
- Publication Date
- 2015-04-22
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of medical technology, in particular to a method for sclerotherapy for rupture and bleeding of esophageal varices. Background technique
[0002] Esophageal variceal bleeding (EVB) is one of the most serious complications of portal hypertension due to liver cirrhosis, with a large amount of bleeding and high mortality. Conservative treatment in internal medicine has a low rate of emergency hemostasis, a high rate of rebleeding, and recurrence after drug withdrawal. However, surgical treatment is prone to complications, aggravating liver function damage, and the long-term survival rate is not ideal. Esophageal and gastric varices occur in 40% of patients with liver cirrhosis, the annual incidence of variceal bleeding is 5% to 15%, the 6-week mortality rate is 20%, and the rebleeding rate within 1 year is as high as 60%.
[0003] There is no radical treatment for esophageal varices due to liver cirrhosis. At present, t...